JPS5282721A - Production of chcken poxx herpes zoster virus vaccine - Google Patents
Production of chcken poxx herpes zoster virus vaccineInfo
- Publication number
- JPS5282721A JPS5282721A JP15733876A JP15733876A JPS5282721A JP S5282721 A JPS5282721 A JP S5282721A JP 15733876 A JP15733876 A JP 15733876A JP 15733876 A JP15733876 A JP 15733876A JP S5282721 A JPS5282721 A JP S5282721A
- Authority
- JP
- Japan
- Prior art keywords
- poxx
- chcken
- production
- virus vaccine
- zoster virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000007514 Herpes zoster Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/25—Varicella-zoster virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
- C12N2710/16763—Methods of inactivation or attenuation by chemical treatment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/821—Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/644,787 US4008317A (en) | 1975-12-29 | 1975-12-29 | Varicella-zoster virus vaccine and preparation thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5282721A true JPS5282721A (en) | 1977-07-11 |
| JPS624370B2 JPS624370B2 (fr) | 1987-01-30 |
Family
ID=24586321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP15733876A Granted JPS5282721A (en) | 1975-12-29 | 1976-12-24 | Production of chcken poxx herpes zoster virus vaccine |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4008317A (fr) |
| JP (1) | JPS5282721A (fr) |
| BE (1) | BE849897A (fr) |
| DE (1) | DE2655691C2 (fr) |
| FR (1) | FR2336944A1 (fr) |
| GB (1) | GB1565830A (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57500149A (fr) * | 1980-01-25 | 1982-01-28 | ||
| US4315914A (en) * | 1980-04-04 | 1982-02-16 | Seiji Arakawa | Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof |
| US4714678A (en) * | 1982-10-13 | 1987-12-22 | Smithkline-Rit | Temperature sensitive strain of bovine viral diarrhoea virus |
| IT1213254B (it) * | 1984-12-06 | 1989-12-14 | Boehringer Biochemia Srl | Metodo diagnostico per la valutazione di parametri clinici mediante prelievo diretto dimateriali biologici e dispositivoper la sua attuazione. |
| WO1992006989A1 (fr) | 1990-10-04 | 1992-04-30 | Research Corporation Technologies, Inc. | Antigene d'herpes virus varicellae |
| US5824319A (en) * | 1990-10-04 | 1998-10-20 | Research Corporation Technologies, Inc. | Varicella-zoster virus antigen |
| PT651789E (pt) * | 1992-07-17 | 2002-05-31 | Merck & Co Inc | Metodo para a prevencao de zoster ou alivio de neuralgia pos-herpetica relacionada com varicela |
| AU2158995A (en) | 1994-03-15 | 1995-10-03 | Medical College Of Pennsylvania And Hahnemann University | Compositions and methods for vaccines comprising alpha-galactosyl epitopes |
| US7666082B2 (en) * | 2004-05-07 | 2010-02-23 | Gamelogic Inc. | Method and apparatus for conducting a game of chance |
| WO2015034807A2 (fr) | 2013-09-05 | 2015-03-12 | Merck Sharp & Dohme Corp. | Procédés d'immunisation par l'antigène du virus varicelle-zona |
-
1975
- 1975-12-29 US US05/644,787 patent/US4008317A/en not_active Expired - Lifetime
-
1976
- 1976-12-08 DE DE2655691A patent/DE2655691C2/de not_active Expired
- 1976-12-22 GB GB53537/76A patent/GB1565830A/en not_active Expired
- 1976-12-24 JP JP15733876A patent/JPS5282721A/ja active Granted
- 1976-12-28 BE BE173669A patent/BE849897A/fr not_active IP Right Cessation
- 1976-12-29 FR FR7639469A patent/FR2336944A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DE2655691C2 (de) | 1985-08-14 |
| JPS624370B2 (fr) | 1987-01-30 |
| US4008317A (en) | 1977-02-15 |
| FR2336944B1 (fr) | 1980-07-18 |
| GB1565830A (en) | 1980-04-23 |
| DE2655691A1 (de) | 1977-07-14 |
| FR2336944A1 (fr) | 1977-07-29 |
| BE849897A (fr) | 1977-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RO76939A (fr) | Procede pour la preparation des purines substitues | |
| GR60854B (en) | Preparation process of benzylidenic derivatives | |
| GR62109B (en) | Preparation process of quinazolone derivatives | |
| GR60835B (en) | Preparation process of delta15-steroids | |
| GR59482B (en) | Preparation process of novel biphenyloxy-derivatives | |
| GR60435B (en) | Preparation process of acylamino-derivatives | |
| GR59280B (en) | Process for the preparation of 1-aryloxy-3-n-substituted aminopropane derivatives | |
| JPS51136772A (en) | Preparation of high ciss1*44polybutadiene | |
| JPS51133414A (en) | Production of vaccine against viral hepatisis | |
| GR60047B (en) | Preparation process of 11-desoxy-16-aryloxy-omega-tetranorprostaglandins | |
| JPS5212924A (en) | Production of virus pesticidal comrosition | |
| JPS5251330A (en) | Preparation of trichloromethyll trifluoromethyllbenzene | |
| JPS51131836A (en) | Preparation of acetoacetylarylamide | |
| ZA765120B (en) | Improvements relating to n-tetrahydro-furfuryl-noroxymorphones | |
| GR60849B (en) | Preparation process of l-pyroglutamyl-l-prolinamide | |
| ZA741441B (en) | Herpes simplex type 2 virus vaccine and method of production and use | |
| GR60822B (en) | Preparation process of novel homophthalimides | |
| IL51013A (en) | Production of ethyl chloro-thioformate | |
| IL50323A (en) | Process for the preparation of s-substituted phosphoro-dichloridothiolates | |
| PT65459A (en) | Process of preparation of pyrroline derivatives | |
| IL49686A0 (en) | Preparation of 3-phenoxybenzaldehydes | |
| JPS5259118A (en) | Preparation of trichloromethyll trifluoromethyllbenzene | |
| JPS5231825A (en) | Identification of virus | |
| JPS5259119A (en) | Preparation of trichloromethyll trifluoromethyllbenzene | |
| IL50634A0 (en) | Preparation of 2-amino-1-alcohols |